Concepedia

Anselmiova Katerina

AK

Statistics

Publications

3

Citations

192

H-Index

3

Active since

2015

Affiliations

Wellcome Trust(Current)

University of Cambridge

Cambridge University Hospitals NHS Foundation Trust

Addenbrooke's Hospital

National Institute for Health and Care Research

Anselmiova Katerina is an author at Wellcome Trust specializing in life sciences, t cell biology, and regulatory t cells.

Publications per year

2015–2018

3

Publications

3

Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial

John A. Todd, Marina Evangelou, Antony J. Cutler et al. · PLoS Medicine · 2016 · 136 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

The DILfrequency study is an adaptive trial to identify optimal IL-2 dosing in patients with type 1 diabetes

Eleonora Seelig, James Howlett, Linsey Porter et al. · JCI Insight · 2018 · 43 citations · Full text

Life Sciences, Endocrinology, Immunology +17

Effective recruitment of participants to a phase I study using the internet and publicity releases through charities and patient organisations: analysis of the adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D)

James Heywood, Marina Evangelou, Goymer Donna et al. · Trials · 2015 · 13 citations · Full text

Public Health, Health Sciences, Clinical Epidemiology +14

1–3 of 3